2024年第66届美国血液学会(ASH)年会将于2024年12月7-10日在美国圣地亚哥举行。近日,ASH已经公布了2024年会上部分研究的摘要,这些摘要涉及的药企不乏基石药业、亚盛医药、 百济神州 等多家国内药企,其将在美国血液学会年会上展示在研新药的临床数据。其中,百济神州将在2024年美国血液学会年会上展示针对多种B细胞恶性肿瘤的创新血液学产品组合,包括:3期SEQUOIA研究5年结果显示...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.